Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 21;13(7):1776.
doi: 10.3390/biomedicines13071776.

Neuromodulation of the Cardiac Autonomic Nervous System for Arrhythmia Treatment

Affiliations
Review

Neuromodulation of the Cardiac Autonomic Nervous System for Arrhythmia Treatment

Benjamin Wong et al. Biomedicines. .

Abstract

This review explores current and emerging neuromodulation techniques targeting the cardiac autonomic nervous system for the treatment and prevention of atrial and ventricular arrhythmias. Arrhythmias remain a significant cause of morbidity and mortality, with the autonomic nervous system playing a crucial role in arrhythmogenesis. Interventions span surgical, pharmacological, and bioelectronic methods. We discuss the range of neuromodulation methods targeting the stellate ganglion, the spinal region, the parasympathetic system, and other promising methods. These include stellate ganglion block, stellate ganglion ablation, cardiac sympathetic denervation, subcutaneous electrical stimulation, thoracic epidural anesthesia, spinal cord stimulation, dorsal root ganglion stimulation, vagus nerve stimulation, baroreflex activation therapy, carotid body ablation, renal denervation, ganglionated plexi ablation, acupuncture, and transcutaneous magnetic stimulation. Both preclinical and clinical studies are presented as evidence for arrhythmia management.

Keywords: atrial arrhythmias; neuromodulation; ventricular arrhythmias.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Neuromodulation therapies to treat atrial and ventricular arrhythmias. Therapies range from pharmacological methods to surgical procedures to specialized devices targeting the stellate ganglion (pink), the spinal cord region (blue), the parasympathetic nervous system (green), and other (purple). Created in BioRender. Wong, B. (2025) https://BioRender.com/5kqb43n.

Similar articles

References

    1. Tang D.H., Gilligan A.M., Romero K. Economic Burden and Disparities in Healthcare Resource Use Among Adult Patients with Cardiac Arrhythmia. Appl. Health Econ. Health Policy. 2014;12:59–71. doi: 10.1007/s40258-013-0070-9. - DOI - PubMed
    1. Sussman M., Menzin J., Lin I., Kwong W.J., Munsell M., Friedman M., Selim M. Impact of atrial fibrillation on stroke-related healthcare costs. J. Am. Heart Assoc. 2013;2:e000479. doi: 10.1161/JAHA.113.000479. - DOI - PMC - PubMed
    1. Chugh S.S., Reinier K., Teodorescu C., Evanado A., Kehr E., Al Samara M., Mariani R., Gunson K., Jui J. Epidemiology of sudden cardiac death: Clinical and research implications. Prog. Cardiovasc. Dis. 2008;51:213–228. doi: 10.1016/j.pcad.2008.06.003. - DOI - PMC - PubMed
    1. Ko D., Chung M.K., Evans P.T., Benjamin E.J., Helm R. Atrial Fibrillation: A Review. JAMA. 2025;333:329–342. doi: 10.1001/jama.2024.22451. - DOI - PMC - PubMed
    1. Samuel M., Healey J.S., Nault I., Sterns L.D., Essebag V., Gray C., Hruczkowski T., Gardner M., Parkash R., Sapp J.L. Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy. JACC Clin. Electrophysiol. 2023;9:808–821. doi: 10.1016/j.jacep.2023.01.030. - DOI - PubMed

LinkOut - more resources